![Pei Jian Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pei Jian Wang
Direttore Finanziario/CFO presso XinYu Pharmaceutical Co., Ltd.
Posizioni attive di Pei Jian Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Direttore Finanziario/CFO | 01/05/2019 | - |
Contatto Relazioni con gli Investitori | - | - | |
Segretario Aziendale | 01/05/2019 | - |
Storia della carriera di Pei Jian Wang
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Director of Finance/CFO | 1 |
Investor Relations Contact | 1 |
Corporate Secretary | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Borsa valori
- Insiders
- Pei Jian Wang
- Esperienza